Jonathan Carmichael
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making.
Journal: Cancer management and research
Published: September 21, 2023
A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction.
Journal: EJHaem
Published: April 13, 2023
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study.
Journal: Cancers
Published: November 11, 2022
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
Journal: Blood cancer journal
Published: November 04, 2022
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction?
Journal: Leukemia
Published: March 13, 2022
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Journal: British journal of haematology
Published: August 13, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
Journal: Frontiers in oncology
Published: April 30, 2021
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.
Journal: Cancer immunology research
Published: March 10, 2021
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Journal: Scientific reports
Published: October 05, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026